{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:46:26Z","timestamp":1773783986221,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11845-023-03464-w","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T07:02:11Z","timestamp":1689318131000},"page":"231-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Donislecel-the first approved pancreatic islet cell therapy medication for type 1 diabetes: a letter to the editor"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9841-7830","authenticated-orcid":false,"given":"Muhammad","family":"Affan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4552-913X","authenticated-orcid":false,"given":"Marrium S.","family":"Dar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"3464_CR1","doi-asserted-by":"publisher","unstructured":"DiMeglio LA, Evans-Molina C, Oram RA et al (2018) Type 1 diabetes. The Lancet 391(10138):2449\u20132462. https:\/\/doi.org\/10.1016\/s0140-6736(18)31320-5","DOI":"10.1016\/s0140-6736(18)31320-5"},{"key":"3464_CR2","unstructured":"Critical ReviewsTM\u00a0in Immunology (2019) Begell House Digital Library. www.dl.begellhouse.com. https:\/\/www.dl.begellhouse.com\/journals\/2ff21abf44b19838"},{"key":"3464_CR3","doi-asserted-by":"publisher","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T et al (2020) Prevalence and Incidence of Type 1 Diabetes in the world: a Systematic Review and meta-analysis.\u00a0Health Promot\u00a0Perspect\u00a010(2):98\u2013115. https:\/\/doi.org\/10.34172\/hpp.2020.18","DOI":"10.34172\/hpp.2020.18"},{"issue":"15","key":"3464_CR4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/nejmoa1610187","volume":"376","author":"EJ Mayer-Davis","year":"2017","unstructured":"Mayer-Davis EJ, Lawrence JM, Dabelea D et al (2017) Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002\u20132012. N Engl J Med 376(15):1419\u20131429. https:\/\/doi.org\/10.1056\/nejmoa1610187","journal-title":"N Engl J Med"},{"key":"3464_CR5","doi-asserted-by":"publisher","unstructured":"Hirsch IB, Gaudiani LM (2021) A new look at brittle diabetes.\u00a0J Diabetes Complicat\u00a035(1):107646. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107646","DOI":"10.1016\/j.jdiacomp.2020.107646"},{"key":"3464_CR6","doi-asserted-by":"publisher","unstructured":"Peters AL, Ahmann AJ, Battelino T et al (2016) Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline [published correction appears in J Clin Endocrinol Metab 2023 Apr 13;108(5):e201]. https:\/\/doi.org\/10.1210\/jc.2016-2534","DOI":"10.1210\/jc.2016-2534"},{"key":"3464_CR7","doi-asserted-by":"publisher","unstructured":"Matsumoto S (2010) Islet cell transplantation for Type 1 diabetes. J Diabetes 2(1):16\u201322. https:\/\/doi.org\/10.1111\/j.1753-0407.2009.00048.x8","DOI":"10.1111\/j.1753-0407.2009.00048.x8"},{"key":"3464_CR8","unstructured":"Commissioner of the FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes. FDA. Published June 29, 2023. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-cellular-therapy-treat-patients-type-1-diabetes. Accessed 4 July 2023"},{"key":"3464_CR9","unstructured":"Cellular Tissue and Gene Therapies Advisory Committee April 15, 2021 Meeting Presentation- Donislecel for the Treatment of Brittle Type 1 Diabetes Indication | FDA. www.fda.gov. https:\/\/www.fda.gov\/media\/147598. Accessed 4 July 2023"},{"key":"3464_CR10","unstructured":"American Diabetes Association. Hypoglycemia (Low Blood Glucose) | ADA. diabetes.org. Published 2022. https:\/\/diabetes.org\/healthy-living\/medication-treatments\/blood-glucose-testing-and-control\/hypoglycemia"},{"issue":"6","key":"3464_CR11","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1177\/0963689718766323","volume":"27","author":"A Bruni","year":"2018","unstructured":"Bruni A, Bornstein S, Linkermann A, Shapiro AMJ (2018) Regulated Cell Death Seen through the Lens of Islet Transplantation. Cell Transplantation. 27(6):890\u2013901. https:\/\/doi.org\/10.1177\/0963689718766323","journal-title":"Cell Transplantation."},{"key":"3464_CR12","doi-asserted-by":"publisher","unstructured":"Handley G, Hand J (2021) Adverse Effects of Immunosuppression: Infections.\u00a0Pharmacology of Immunosuppression. Published online 2021:287\u2013314. https:\/\/doi.org\/10.1007\/164_2021_550","DOI":"10.1007\/164_2021_550"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03464-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T05:49:57Z","timestamp":1706075397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03464-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["3464"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03464-w","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research registration unique identifying number (UIN)"}}]}}